Rare Disease Innovation Act

1/11/2023, 1:29 PM

Congressional Summary of S 2188

Rare Disease Innovation Act

This bill amends the Federal Food, Drug, and Cosmetic Act to expand the humanitarian device exemption to authorize the Food and Drug Administration (FDA) to exempt from effectiveness requirements certain medical devices intended to benefit fewer than 8,000 individuals. Currently, the FDA may exempt devices intended to benefit fewer than 4,000 individuals.

Within 18 months of enactment of this Act, the FDA must define “probable benefit” for these devices.

The FDA must report every five years on the effect of this expansion of the humanitarian device exception.

Current Status of Bill S 2188

Bill S 2188 is currently in the status of Bill Introduced since October 21, 2015. Bill S 2188 was introduced during Congress 114 and was introduced to the Senate on October 21, 2015.  Bill S 2188's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of October 21, 2015

Bipartisan Support of Bill S 2188

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
1
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 2188

Primary Policy Focus

Health

Potential Impact Areas

Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationHealth technology, devices, supplies

Alternate Title(s) of Bill S 2188

Rare Disease Innovation ActA bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the humanitarian device exemption.Rare Disease Innovation Act
Start holding our government accountable!

Comments